ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,228Medicare Part D Prescriptions Filled, Including Refills

Rank: 445 out of 6645

$543K Total Retail Price of All Prescriptions

Rank: 1021 out of 6645

664 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
19% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 664 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

12% of this provider’s 664 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 12,253 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
METFORMIN HCL 680 612 1 7
AMLODIPINE BESYLATE 594 591 2 2
LEVOTHYROXINE SODIUM 556 501 3 4
SIMVASTATIN 540 507 4 1
OMEPRAZOLE 463 404 5 6
LISINOPRIL 438 407 6 3
METOPROLOL TARTRATE 428 414 7 13
TRIAMTERENE-HCTZ 415 385 8 52
LOVASTATIN 401 374 9 15
HYDROCODONE-ACETAMINOPHEN 391 281 S3 10 5
LISINOPRIL-HYDROCHLOROTHIAZIDE 314 309 11 37
ALENDRONATE SODIUM 274 274 12 14
ATENOLOL 267 251 13 8
LOSARTAN-HYDROCHLOROTHIAZIDE 258 254 14 62
LOSARTAN POTASSIUM 220 206 15 12
FUROSEMIDE 183 163 16 11
SURE COMFORT ALCOHOL 176 170 17 250
SPIRONOLACTONE 162 157 18 85
TAMSULOSIN HCL 142 141 19 22
ZOLPIDEM TARTRATE 137 115 20 17
ISOSORBIDE MONONITRATE ER 126 125 21 66
FINASTERIDE 125 115 22 73
FLUTICASONE PROPIONATE 120 119 23 26
CITALOPRAM HBR 120 108 23 35
RANITIDINE HCL 116 105 25 51
ADVAIR DISKUS 116 116 25 45
TERAZOSIN HCL 115 114 27 48
METOPROLOL SUCCINATE 112 109 28 24
WARFARIN SODIUM 111 111 29 16
GABAPENTIN 109 105 30 18
ALLOPURINOL 108 93 31 31
BENAZEPRIL HCL 108 88 31 21
HYDROCHLOROTHIAZIDE 104 101 33 9
DOXAZOSIN MESYLATE 103 95 34 81
GLIMEPIRIDE 98 96 35 47
DONEPEZIL HCL 91 91 36 27
CARVEDILOL 89 88 37 25
PREDNISONE 85 85 38 57
IMIPRAMINE HCL 80 70 R 39 446
SPIRIVA 71 56 40 65
SERTRALINE HCL 71 62 40 43
LANTUS SOLOSTAR 67 62 42 139
NAMENDA 66 66 43 41
DIGOXIN 66 66 43 59
COLESTIPOL HCL 65 64 45 457
JANUVIA 62 62 46 38
VERAPAMIL ER 57 57 47 154
PEN NEEDLE 55 49 48 159
CLOPIDOGREL 53 48 49 36
POTASSIUM CHLORIDE 53 41 49 28
FELODIPINE ER 53 52 49 105
LANTUS 52 41 52 50
DIOVAN 52 52 52 19
ATORVASTATIN CALCIUM 51 41 54 10
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 15, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.